MENU
Home
Add Document
Sign In
Create An Account
PDF Reader
Full Text
Suggest Documents
Monoclonal antibody therapy of cancer.
Complement in monoclonal antibody therapy of cancer.
Advances in dyslipidemia management for prevention of atherosclerosis: PCSK9 monoclonal antibody therapy and beyond.
Recent Advances in Monoclonal Antibody Therapies for Multiple Sclerosis.
Monoclonal antibody therapy in intra-abdominal malignancies.
Humanised monoclonal antibody therapy for rheumatoid arthritis.
Monoclonal antibody therapy for Junin virus infection.
Regulation of complement and modulation of its activity in monoclonal antibody therapy of cancer.
Monoclonal antibody therapy in the treatment of Reye's syndrome.
Monoclonal antibody (MoAb) therapy in non-Hodgkin's lymphomas.
FAT1: a potential target for monoclonal antibody therapy in colon cancer.
A Review of Anti-Angiogenic Targets for Monoclonal Antibody Cancer Therapy.
Monoclonal antibody therapy of human cancer: taking the HER2 protooncogene to the clinic.
Advances in Antibody Design.
Pancreatic cancer: advances in medical therapy.
Macrophages eliminate circulating tumor cells after monoclonal antibody therapy.
Reversing EGFR Mediated Immunoescape by Targeted Monoclonal Antibody Therapy.
Monoclonal antibody therapy and renal transplantation: focus on adverse effects.
Intraperitoneal yttrium-90-labeled monoclonal antibody in ovarian cancer.
Strategies in antibody therapy of cancer.
Production of monoclonal antibody to human esophageal cancer cell line.
Advances of Molecular Targeted Therapy in Gastric Cancer.
Recent advances of sonodynamic therapy in cancer treatment.
Advances in biodegradable nanomaterials for photothermal therapy of cancer.
Advances in monoclonal antibody therapy of cancer.
Tumor-associated antigens can be seen as unique targets for the delivery of anti-cancer therapy. Monoclonal antibodies directed at such antigens are i...
1MB Sizes
0 Downloads
0 Views
Download PDF
Recommend Documents
Monoclonal antibody therapy of cancer.
Complement in monoclonal antibody therapy of cancer.
Advances in dyslipidemia management for prevention of atherosclerosis: PCSK9 monoclonal antibody therapy and beyond.
Recent Advances in Monoclonal Antibody Therapies for Multiple Sclerosis.
Monoclonal antibody therapy in intra-abdominal malignancies.
Humanised monoclonal antibody therapy for rheumatoid arthritis.
Monoclonal antibody therapy for Junin virus infection.
Regulation of complement and modulation of its activity in monoclonal antibody therapy of cancer.
Monoclonal antibody therapy in the treatment of Reye's syndrome.
Monoclonal antibody (MoAb) therapy in non-Hodgkin's lymphomas.
×
Sign In
Login with Facebook
Don't have an account?
Forgot Password?
×
Sign Up
By clicking register, I agree to your terms
